首页> 外文学位 >Evaluation of the decomposition kinetics of thymopentin and its analogs by isothermal and non-isothermal methods.
【24h】

Evaluation of the decomposition kinetics of thymopentin and its analogs by isothermal and non-isothermal methods.

机译:用等温和非等温方法评估胸腺五肽及其类似物的分解动力学。

获取原文
获取原文并翻译 | 示例

摘要

he peptide, thymopentin, has recently been used clinically in the treatment of auto immune diseases, rheumatoid arthritis and as an adjuvant in vaccinations. The proposed stability studies of thymopentin are challenged with two main goals. The first is to develop a faster, more cost effective non-isothermal method that could be used in lieu of isothermal methods. The second goal is to enhance the stability of thymopentin by manipulating the peptide environment or its primary structure. Hopefully, the results of this study can be used to better understand the chemical and biological stability of peptide formulations in general. A greater stability is desired because thymopentin has an extremely short half-life (only 30 seconds) in human plasma, which is due to enzymatic degradation. The proposed stability study was quantified by isothermal and non-isothermal methods. A comparison of the kinetic parameters obtained by these two methods was also performed. The traditional isothermal method of achieving stability is undesirable due to the high cost and limited supply of peptide pharmaceuticals. Therefore, the development of a faster, more cost-effective test for stability would greatly aid experimentation. A non-isothermal method would use less of the product and take months off of time required to run trials.;The proposed studies investigated the influence of pH, temperature, ionic strength, and buffer species on the rate of degradation of model peptides. Four approaches were designed to attempt to prolong thymopentin stability and its circulating time in vivo. The first approach was to create pro-drugs by substituting asparagine for aspartic acid in the thymopentin amino acid sequence so as to increase the circulating time of thymopentin. It is hoped that the pro-drug will revert to thymopentin by a deamidation reaction. The second approach substituted tryptophan for tyrosine of thymopentin, and then increased its stability by using
机译:肽胸腺五肽最近已在临床上用于治疗自身免疫性疾病,类风湿性关节炎以及作为疫苗的佐剂。提出的胸腺五肽稳定性研究面临两个主要目标的挑战。第一个是开发一种更快,更具成本效益的非等温方法,以代替等温方法。第二个目标是通过操纵肽环境或其一级结构来增强胸腺五肽的稳定性。希望这项研究的结果可以用来更好地了解肽制剂的化学和生物学稳定性。期望有更高的稳定性,因为胸腺五肽在人血浆中的半衰期非常短(仅30秒),这是由于酶促降解所致。拟议的稳定性研究通过等温和非等温方法进行了定量。还对通过这两种方法获得的动力学参数进行了比较。由于肽药物的高成本和有限的供应,因此不希望使用传统的等温方法来获得稳定性。因此,开发一种更快,更具成本效益的稳定性测试将大大有助于实验。非等温方法将使用较少的产物,并需要数月的时间进行试验。拟议的研究调查了pH,温度,离子强度和缓冲液种类对模型肽降解速率的影响。设计了四种方法来尝试延长胸腺五肽的稳定性及其在体内的循环时间。第一种方法是通过在胸腺五肽氨基酸序列中用天冬酰胺取代天冬氨酸来创建前药,从而增加胸腺五肽的循环时间。希望前药会通过脱酰胺反应还原为胸腺五肽。第二种方法是用色氨酸代替胸腺五肽的酪氨酸,然后通过使用

著录项

  • 作者

    Lee, Mu-Lan.;

  • 作者单位

    The University of Texas at Austin.;

  • 授予单位 The University of Texas at Austin.;
  • 学科 Chemistry Pharmaceutical.;Health Sciences Pharmacy.
  • 学位 Ph.D.
  • 年度 1996
  • 页码 214 p.
  • 总页数 214
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号